Randomized trial of surgical cutdown versus percutaneous access in transfemoral TAVR

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 3, 2014, Pages 457-464

  Holper, Elizabeth M ^a   Kim, Rebeca J ^b   Mack, Michael ^c   Brown, David ^c   Brinkman, William ^c   Herbert, Morley ^a   Stewart, Wells ^b   Vance, Kaitlyn ^b   Bowers, Bruce ^a   Dewey, Todd ^a  

^a MEDICAL CITY DALLAS HOSPITAL   (United States)

^b Cardiopulmonary Research Science and Technology Institute   (United States)

^c The Heart Hospital   (United States)

Author keywords

valvular heart disease; vascular access complications

Indexed keywords

VALVULAR HEART DISEASE; VASCULAR ACCESS COMPLICATIONS;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BLOOD FLOW VELOCITY; CARDIAC CATHETERIZATION; CATHETERIZATION, PERIPHERAL; FEMALE; FEMORAL ARTERY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PILOT PROJECTS; PUNCTURES; REGIONAL BLOOD FLOW; RISK FACTORS; SEX FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR SURGICAL PROCEDURES;

EID: 84893462671     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25002     Document Type: Article

References (17)

1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
2. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
3. Van Mieghem NM, Nuis RJ, Piazza N, et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: The Rotterdam experience. EuroIntervention 2010; 5: 673-679.
4. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55: 1080-1090.
5. Ducrocq G, Francis F, Serfaty JM, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 2010; 5: 666-672.
6. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009; 119: 3009-3016.
7. Tchetche D, Dumonteil N, Sauguet A, et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention 2010; 5: 659-665.
8. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011; 32: 191-197.
9. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763.
10. Hayashida K, Lefèvre T, Chevalier B, et al. Transfemoral aortic valve implantation: New criteria to predict vascular complications. J Am Coll Cardiol Interv 2011; 4: 851-858.
11. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: Vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012; 59: 113-118.
12. Hayashida K, Lefèvre T, Chevalier B, et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: Impact of learning curve on vascular complications. J Am Coll Cardiol Interv 2012; 5: 207-214.
13. Saia F, Bordoni B, Marrozzini C, et al. Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. Future Cardiol 2011; 7: 321-331.
14. Wenaweser P, Windecker S,. Anatomical suitability for transcatheter aortic valve implantation with complementary roles for 2 rivals. J Am Coll Cardiol Interv 2010; 3: 867-869.
15. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011; 57: 253-269.
16. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2. J Am Coll Cardiol 2012; 60: 1438-1454.
17. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-2747.